Incidence and risk factors for musculoskeletal adverse effects associated with daptomycin in patients receiving outpatient parenteral antimicrobial therapy

Abstract Background: Daptomycin is preferred in outpatient parenteral antimicrobial therapy (OPAT) due to daily dosing. Elevations in creatine phosphokinase (CPK) of 3%–10% and musculoskeletal adverse events have been described with daptomycin, but data regarding risk factors and frequency of moni...

Full description

Saved in:
Bibliographic Details
Main Authors: Meaghen B. Wiley, Kiya K. Bennett, Emily A. Siegrist, Stephen B. Neely, Joseph Sassine, Bryan P. White
Format: Article
Language:English
Published: Cambridge University Press 2025-01-01
Series:Antimicrobial Stewardship & Healthcare Epidemiology
Online Access:https://www.cambridge.org/core/product/identifier/S2732494X25100879/type/journal_article
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items